<?xml version="1.0" encoding="UTF-8" standalone="no" ?><TrainingData><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="20">6E0000008C4C2480A48F1B407476894B8ADB3540FB4193E64A06524064AF3E9F62F14D40C2C36DE2AAEE3340550A8D685FFF14401BCB9ACA557F2740A837A4EA343E4B408280EFC5FA764A403521125B43FC36401CF3F7E112F20A4025ED955F79292D40BF6730F427A74D4050D0CD2B1A444B40B0D4D6F4662B3140B6AFDB10DF710E40755AC1C97BF23440105F19EBAD155040C718E67A631450403145C8C9F08B354048FDA089C150114099D55BD9F5342B40EA0B0517C4734A402EB78C2CD4284840722E112FAEB938402136A8114B591B40EE0B040770F32740B59E119FAC3E4040F6316380A6F24640228E72599A6E4140C3584952F2FB204016AF9D21052E28405AA433876DD541404B639AE782D74F40625E5823D039464020C43E4578F70B408402811FB1821740D85E261AEC5A36405654ACBBD3A63F40B9008BEB01723340DFDB17C35AA9F93F493539A26B2E1540D721960488552E40B8ECEC4FCA36374060412EAA0B51244009C0E8CF69761040A788A6CD0F0B2440BDF6E98124543740D5839655260E42406F78AF8EC90D2940018ADE5FD2430A40A62C1462C0CD15409EDE341E793630402EBC4BE68D3C3A40735CC9E732342D40F72AB91F19A80E402971391E4DD713407F4D745581C1304093C83F34C554414020264498481C36407B772F2151CB2240E27974C43C86324018D3EC6A77B640406EFCF00706E45440A853D3D00F164B4057F79EF53F3C1340D03BDCA8E9B822409378909B0FC54A40125B4E80741D4B40080BE1A7E3213640A35CA4410E05004090F7F2954E7016404FDF0B41437A3540466EC54A05A93240F258F20DD16D1F40B053AE384E090B4012B49E1187DF19400BDFEF8FE3E1314037AB10A93974324025162DA1B35A1B4099CCB0CFC3DD0540BA99810FF64B1640875BFA7C908231407F328DD8C72434409E3C670B3A1422402AAC42D675C90540D8B69F289D7B234066B911FE88CC4940E3A83BB3CE3E4E40FCA57A7D82613840141E182B966D1140681C4F60669829408CD6A0F4DB5E5140E5595E81D5BB5040D47FC49F7EA63240524E728E80040840B502A245060425405FE437E638854B40D212EE4D9BA14A403D958304F60531405873298836B00A403859D694292C29407D7C66A1C40F4F403633414E73D75040B6380D1A5AC139404B974E6203C72140D8F9B09013503A405AE0E1A9A3A955400A6935351FA2604003C90C2201AB4A40</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="31">6E000000D856C487B46118409FBD3EC9DD69344038E43F7F57614640E2164DEEED4D4840C94D1C79E0F03B40F4BDFECE9621144074A6D6861AD02340E8D2D25D3CFC3F405CE22D246E8345400D83BEA3413738409498B1F76D901040FA4A702024E1264064E50FE4B8373D40B305AFE18E72414048E7BA166AA13140677BF3F4FD4A15405B3A353C6C572D4014AB3420EF2C3E409C05F67572354240BB8E3061276036408E244B92084D13405B0F385B343C274022B6788C1DB439405689C8519E6C4340BFC11F47842C3C40C37DBAD337D51C4002ACC10632872A4055C6BFD9401A3B4008103975054A4540EFCAA3688C9C4440F140FF0213F823403772C895607E2D403FC4DD26DA2D40406AECA2DB5D6949400415B34B7D673A403A8DF423E0650940E1093F7EE24C15405E27BBEE6DA53140120E77E4DDBF3C40FA2D92FBE02B2E40B0489095E28901401789BDE2061110401038BFDD375A1F4029F7D0A072832E40A4A567CD740D2140B4B202084AC610404741AD1511AC18401344813DF79726408FCADFF081C63240181AAE9F9DC32540FCDE8364BD2C0440BD5A6CAC275911408A47DA7533E122407E7CC7C768E83340EA2F102546722840FF8ED489E70210406E42864A774615408113172A69F036409C534B1FE04F41408812D61363573340763E42D6F0162840A817B020A4A02C40F80A6DF0E6AE414075036C11D78F4D40FA378D19B4DB3C40C87ADF87B3530B405DDEB2061CA025403395C9555684474029CE180BB0624640F63E1F0195F731407C1BB6405EB2FE3FF741E5EAD46019402DA61CA240603640540654DAB82E33402550FF5D36FF2040CBF2E485ACC107408A4446CAF84F1240E5CE2717483829408A16B6C71C5D2F403A59028DE020224045B625A88769F53F2F4DC38F591C06404B52895CA8702140F7E9F2659C6A2A40AC6D7EF1F64F1840EE2332C91BC00640620E6DE84AFC13401CD02FE8E3683A4082CA53E3F8F841402E9EA1F5980E2B401BE33DBB5D2813404498138E010F2D409EC6D4B8B8484C406C57BC101B1E4940A6773763A27435409486AA9680730E409C708F526DD727408FD37A63327C4440C689EDBB76C94240B19831BE96C53140FECCB921017F1040F92CF087E1CB2440A90F6F1BA13F414034221EE7E9504440F05E109E443436405006CCE7716428408FD0088E0D913A40AA1F64656EC351406D79B5401490594086AB9644537D4E40</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="34">6E000000E097717F51EC19404746061C3BAC2F40ABB40F171DE54A40C9A2CD87F92E47404164281B7D5E37409EE72782DB85054047F1FD334E8E2040E1C725D25A664340751AC0E768C14D409169841D111C4040A3C920489E4709404C1571CBE1912240D3D030DBBA844440C3992F68F7974440319AC90F1E873340045E7671F1D01640C5190E12164E2740BA81402B9A9A4740AEAB04ECEEDA4240BE8367667DE22E402599309629430A405BB6065D99C721401CEBC185062844403AD792A3D205424059A6A78C778B30400A3E5B41C714074070EB1668F27320406E6A4972E50140403EB42E22A72B4540AA7B4FD911BC41404CDA1FF4C2572640545D550BF4E42540991D8106697F424028B2D935D42B50402C1A5D1FAF284140992A87269BBC0340616C6D697E001140F4B51289F9143E40491CAC82032146407F3F28D498FE3140CC1DB55DD270FB3FC5E5A332C99A1040DB84AF29EB242F40472B52E4D9493540846A3BA0FDDB24404C5E4760A6640F40A95715DFD6D51F402F8AD209978B3B4007D7AF2901CA354052E5AA026B9C2140AE59D2A665EAFA3FB25326C2AAA2114065B8EE4B148C39401DF11AED6B213A4025A0997769422640B11DFD925BA2FB3F33B8572C226A144030245878938A454045C3FF52F4044540425F014A267F3740780D233DB2481D4080BE1DF6C7F32340DEC9BF17F0E84A40497E55A666195040F4E5C9B41C873E40F2E2DB50494C0640798CE152106120405BAFF259736354405C2B025F9FD2494000A2ADB4B1CD2D40E941EE388C1AF63FDC451D8130021240A666AF7079693D4007A122C832B033408287AB4976E121406A8B70C3249AFE3FBCBE4B513F830F40696FE5DD79752740BF428797535F3040FCC0573CCE0B21409DFD0F2D7238F33FC551633ADB470D40F8425E5BE3C92C40103F10F661DF3540BF1DB8948805224099FC28E98C8D054030642F2630731B40843CEBA55B434E4094DAFEBE385849404BB662CC80223240E6C88F0ADB081040699F6FF90A7F2840946AE01B22515140B850435F4CF14740AFB390684C022940D66490A2A7E2034004AEB362CF4B1F405A74077B124443404EB5DBC55C4C43406C380CB81B4F2A40CAE633167BB51240D8D3A900E7E62240388A809AF88F4740E2F9D442940F4B408F23BE25C7E1324067CF1E753A0D28401F3E24F3AA533640340417B3A071504043EFBBB76B7955400672171275144140</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="36">6E000000F40EE927046E184026076B380D5F2C408B75FE1474BD474043956AE8255A4840F9E0B0A2FA023B406F8554BE77051D404BA68569D4C3254000E058273F204440777F2A5D78004B402E89D1773E9C3D4033711233C9060C40B334EEE8BF5A2440521E1DAA829A4440A2CC72904BAF4740F0C80B8B1E24364098F5A1A9B9260E40F3D42EF3D9B82940AF80DD52E97547402E1A28419B384640A8B46C8018C43340D41F28AB06A71040DE2E901C3CCD234061968C382FEE4140DB446C6ED06F4140842A556035A73B40CA5681C21EF1144067D57292D55723400B9F6F47A7E23A401BB27558B8C4434041B8D85458AA444004EC4F8EC1E121402BD0F9F6652F2640CC462764337A45407CF4D080A10F4E404F8C290CAEA54940448AE893B21B11409399CD3ABB851640A676B807453F4040FAD9C8037C09444093A8AEE94DC53440882E5C158B170340975C55686E6D1540C9B765508ADE2D408ACB135AEED438408B511F3D93512B40EA660A5B09AB174037794A70DF10254094D7A7745C9C3340E3607DC783B83640DA02673A63182640882920B6BDF90340DF092C9555E112400C2A2C483BA83340C64537C946003740A9162A8639922C4037D190E5CF90FC3FB586B3D0AD991C40C2A50E32D05A4440BCE58285D51F4540A6D713CCC3433C40EA32A97E49C421408A61CF4F2DD129403B737FA577394440317B07494CA35340DC1286CFA19B4F403E75FB30415C0C404FD70331226D174080B61C30D97450404C163C4EDB9F4C40A9FFCAAF6064354043C45BDF37EEFF3FB4229AB4197B0F405111470717453640D5E5E793B33D3640EFB60241F04C2640B82F744E98211340E991E0021454174001F7AC97F7732940BA289835707B2A40F4AF44BCF5961F408D02E2B8E7860240BD4D53DF988212402353B2C826293A40C818138BD500364041580BE5CF6D214096309C18C91D08406ECB305DB37C274049A183E4E9B053408F950EFE3E5F4E405FE9A642FDFA35403865E83F171D104073E5563791261E403F78B1A6ACC34A40914B7B23FD5B4A40B76E146D6C6936405ECA77A54F140C409A091E268E171E40CF341BE57410434022739A3309134340AF16D20B07C630408793179411B412406D706BE706072940286C1B0DAD3D4D40D2977123AE564D405880EBFA3D5834409855CAC555E225405D514F413AB43B403B16920E4D085040763602F8B52E584051EF9613BA954740</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="37">6E000000E4EC3FEF09FA254055AB51B90EF12C405EE2066FECE244401A60972FA3464A40F04F6F73597F36402C2068B33BF71E40FF9FD093CBBE22403C912B6A963940409D0CD0E02C2C48403A07F7C6B85635407DF7C3FA5A631140ACFC030534C222408E6C534248664240AFA6A3F3CD8D4440AC0FA80C935D3040B53133D6E4651540A6D4A88FDB4922404CFF30FBB63C4540DC76556B9E8B474070D63D9720B53240CF408DF1ED941140222B7CCA90411D40F0E05262424C40409E41BC6038C643407D5318BA3EA03040EDB913B81C5E12404270C0142DD21D40BF42BAB603913A403009EC06C5774740C2401C9767B13A40DAD8EEEA247E244076401586367D27405078E41B648F36408286DD1A97A44A4037BA82A79DC54240CC6A4AD8012E09409E9DC8A70674134029114CD488563040089C34562A003C4028460D9AEEBB3040ADE9F8A39863FA3F1FBB16C4203E0740B59499345FBA2540CD50781D822B34403BB16A7D948F23403F05AA1843F315404386B2D460801C4038CCB5FE24223240C42EB3B649413840C42470198CC22740FB9A9A398EB6054087B0012CCD1214402D93863731EF30402F23D74DBC673840D00FCFFA7D662340DD3C1F7F1FAC044052FFCD7E18201F40425AA1D814844140EE190BF760E34640AB04BB0A2D633640F69A187AA31B1E4082212EB3ADE0264077B3BCF4B08B404080D17B4FDAD45C407A6C1E82CC615140E60A57BB688D0A40876B0D40F7571A40B88E1366118A44409F672E00FF164240F5AF5D165A1F3240D7F1C93EE660004010CB82B41CA30A405AA095EFE0BE2C4055466E63BA0D3340906B7B7FB1212440E82B51EC8BAD0E40896F2A351F691440A215A67DE9B71B404C0A5B44A7FE2B404786567BEF1D23408566C61E45150140993D03DB0A1412405F3B654044DA254038DF7C9CF1C0314063148D1868CF1B40DC85855C86F30C4036D7E9864F2F21400024B353D1D246403DCF6D239C6D4E406D206D7D3B3534408D2723BE4C311640C900E01D45332040198E275D21574740BD62DDF0FD9F4640377407544D56314071E7223B108D14409470ADB6D4891940E65E65122C273E4067A945F139434340924904A29F4C3040A57E648C958E1640022156C041DC19406CDF92214D19424035D70192AE9D4A40EF7F1491F02E3340B9B2E6FE4DEF2B40DB45F5B04B0F314021F276EDDE1151409C2501218A1D5A406243E87D68444740</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="38">6E0000004FFC59351B1317402B16020775D53140EFC9F90F638B4E40F8BF73FDC7324A4070E5E2BC88F33840E8D07FC47AE61240AEEAE8C352D42940244F85B984E84440374FD4E7261B494031B67F961E4C3640962AA18BBC230840BB31B1795E012B40894949F10DE34540D1B4BB0FDE07414090215B77A3DA2E408828550420B01040D24F40B8D5DD2940F093EE2002194940A306A0825E594440E550A2EF14DE31408E35FC6F2C4E10401FCF42ED6E11204011208FBB124E4340F8E4C2284ABA45408D426CE722033640434F77CF74B91140064B9AFDE0EE1F4052AAF6D0A23D44407D5E47ABB3334B404A5840D22BBB40401A22317A11042340DF28CFCF51D21D40B651368D5A523B404F1B6B51E7ED4A40CF06F8E890DA3C4058F6E9AEF1D10D40344EA0236057124085A755C82A9931409DA4E7BBDD4340405018B8F9B8D42F4032E5EE047A06FD3F26A03C686F03124041AE9578D3172A40C95DBC6E6EB93140B7B0A168E6AF2140A5D7BFA2599D0B406512EC2559A0184091F3C0FF5D30324051B282D56B3B304029D8C5B9815C2140BDF43B82A1DE04407AF3D90288990540AC8B8327DFB72640528832A888A43340B340F2F654E52440A3FBB9D59EB9044050117F950A7A104029F70FB898953340501B58846E123E4037A4545522CF314043A68D14A131154066304FBF55192E40E9BD20F36D643A4052C7BB123458524098FA531140F44D40EABE36EF8B6E14408BFE34F3F6321C408C624DB3160B4440CD0959518B434440849B38DF0C283140AFAFF0B87C41F83F70FD41C0DC570F408D207E4E12053240BDE34B9A30C93240237A1C50CCF92140F8AA48C68C360040EA00E5AC046D164047C5299491A12C4036FB32A975C92F4034F8A1FF9DB124409C9207D8C783FD3FE0CE27D72C3B1840715F84BFB52039405128310B682E3340719221A8C11C1940D5E5125DF02E044092AF819B5570234093A49956FCAE4A40E3EAFDB41240444030CE7CA2B3202940550553BB228E11404F594F026D7425400CEE76D197D04D4091E3F4F9838B4C4050581E5A150B3240A4BF648AF48009409B95B35C39972740A1D4AA9699824E40C9965E1215F2474018F7A03BADB93040B84D6FADD7670B40A8077A60F2AC2F40CAE7F36A64115540E884F53C4C9F4C406100D3709E7E3340A2470242CE282340917B8C93E7213740D5975E5AB3495440020C3FE366375C40425EE36D95534640</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="48">6E000000F038D42B6B2530407D6EFEFFCA2532400DE7A4A8FFA4484026CA9BCD73BF4540CA74C6BB94AA34408AD3E39AD6F41440AB6C4A5D91A42F40A39D3E2F88044440639C6E6C6190484093C53978E3713C4001F3ED11C3F41640B0AA29C08BE922402EABDC2B6042444046A8EEF03B0F424043E1FE3E7A963040FD2E604587DE1540DE5DEF992A462340186D4849AB354840E3A6C1E4600044405B594DEC5C3130406896C1D2D4021B406EC80852145D2140ADECE0FBBAB93D4056C7C947CF003F40FE9798E00D4132403D008D30FDAE22405204BE0E1B8B2240B7B4783DF44E344068C22F58143A44400E00EA2D763044403FD28FF2EFF01D40D7D6BC9E61B42D40F0D918505EF835408E1516AECB724A401DC0A5C72D3C4140357B8431DF2102403925324460A12040337E9F5AD1A82E403C4DF51697CB3C402F3C3624E1D63340C26D6D72A356F53FCBC218B7BBA30440D9C532ED03E52A40AC154FA47F393140BD094EBE86CB2540ECEE0A76BBA1004047C8846561271140E5A7728976853340EA0A1E839CB735407490B8CDC2432440611508A9E13EF43F283F3C353A900C40AC25DBADE5141F40AF66483091CC3440BBEA06E04C632A4088BD5FD1605A0A40E690266DF62C1640E089776822473C4039F5F063E1A04140F3A83671D6B53840749A126FA938274013DEC7711B932540E1D377F0B18742408D42FC8BB7DB4E40F82F8A0C2FA04640D26FD42AE62913402FAD491E5A7B1D4007AF0C12D1443640DB0376ADDE6A3E40D7AF6129D6353240FB9223EFEEED0740E4358A4D5DA10B406405F09F7E612140F710F7CE0E022D406515147F73CA2340748719D5FBBD0E400AEF1EE80A5E1740B7A3BFB8D726214019F5045576672D401E5CE392E5A22140F2A7780C2141FB3F9AE1E759BB7114401C1F5DA0FC85304054FD5D3AD9082D408E58410A07871A4002F0E684F73E04406EA1A431927822400F59A9081AEB4F40B65D59F6EEBD444093534F0FC8833040A077260E357A1D401050653369A01C404D610C987A603F40B589DA429C3D4340207F820384A72D407ED4559D46051A403B336A9E3E9F1D40D7BD64D0B20C3C40196B414617774240240165C608542E4075ACD1768A8A1540F06F6C5A7B5C2440A09A81FE6D6B4740E1300DA9B7E04840E41FD127EE2534408DDC391E3E472540EE10915865682B40E3EA228947614C408BB95ACC511C5A4034B4C72AC5FA4640</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="64">6E0000001ED7F365796E2F404ED63567A1243540C606ACC524B94640B0495DC70AF845406CAFA2CF504738400948C6FA05021540EEE0B720E33F2540E1953CAF2BBD4040C7AE975C937543409A0E3348D1AF3540DC2BCFE0064D1440A693C37CF5381940D48F9B5688374140DC2BBF31205442402EC01A86F5163040F1138DC0010216407F6C560B79FC2640517360B8D174414069B05FA759714440E6D5FC5569F62E402F3AFA7F2ADA0E4033EE67E4E64322406C372A7F5D1B38401E76B2ADD2D040403FF5311363603540D74851970ACA1740BB05CB538BD524400DFDA3A604E73B401EE4B675FA574740DB5C71A120DE3F40C2112A8590DF22400EBEAA7BF7672E405460F5F167C340409691F8DA63FB48407A2ACEB3333941403D52EE224308114064C3104EE18B23404A415D5FEF5B4340AFED8F519C463F4003A14A6DC8B12A4054F2854B731E0440216212EF72F51040C30337F42A742D4041E1BEB663B134404719A4ABB55523402B6AD051867009402776AE5962111A401A515E14ADD22F40822F61A88D19344085988C158ACF20409E037C2A808EFA3F84EA7533394113407BBA2EA9D7F726404D49505BBB2C334008EC7557B52F24404853431A6CB40A40BA903AE180441E40557F8F8CBE5C3F40730CDBC9EA114340518B67A80A023340D86661742E9C23403C1AFE23BF9A2E4092BE0C09E92845407CC548F87A1C5040B3B360A89D5E40400B43529871651440EE29C898AED02B40A11B08995C195240F7E3635D9C8345404257B0F6DB073040C9CA95F88BF0074064A96551A67D1B40666D63E52A073540084FB25A234233403E6C06785B472340C4102123EEFB0640DE1DAF64FD871540244BF226CB411E4098D560A2911C2B40BCB1BA1B634B2040F909CCE585F7FC3F625249DB13881140FD70141E5B7932408BA4C42817242F40178C1F888A891440D81E61464ACE1040A4501FDE664E2140AEDE2B597EE24940C62D8F26DF354640761F04C8A9222940F9686C1F2B4414405C26A30F664E2340A5BF42C61A4F4340DDB42D1EBCAD44404159FDD2A53930400AD5C63F42F90F402535C88468C01540A3155FF041A138405FA6361D34CD4140F84021622D742940EAC2A42212D31440C6D0D6BF5C891A4059B94ECF7B474640F542A2B9D3C24740C9CDA21C0BA92E402F00EEA7C7262940A34677D8CDC12D40C1329D12A6184840ADF641EBB6A757406DE7563F9B374140</Trial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Foot - cue onset (BCI experiment)" Id="71">6E0000001A33EED1487019406415DC50304931404E29BB32F6304240941EDCF3063E48404B85D0B105F3334083634B708B91134032D5AEA257C92340F8CEB44AF5283E40CAB214B1099447402FBDE11192663440FF0E2952D0F31240A6D0D4A84BF02A406FCBE55C82CC3C40CCE585B4D0194340BAAD80DB757A2F403B03952E8F9713408701FB458BBC294020F6279510F13A40D5CAF65A20CD41405AF875C1E83E3240410961050EDD0840CD3CAC79ABB12040CA4272AD96803440103F9041175640400735B477578E31408CD920636B1B0840A1032E2AB3322440E624B7608EB13440EC568B3BE1524440B6EA1EDAC9783E40F4F0E1A72D8217401B8DEB069A7C1C4019622E23C0AC354069661321B6D649401F4A9D8379E33C40FE7F21704E8101407867A935803D114006AFF6CC512C3740187255D98CC840406D194D0692A32A405BA397B6CDD6F83F3D212CD6168C124097BCC72089AD2340342009EE7C8A3240A042744B90B6224022AE9969BC1008406CEFA25BFC581F4070B60A593E6F2340A19F23B4E57B3040EC40D09DFE20234045196F50D48FF63F3711BAEE6A5404402F2728D2018C2140DBCAA9F542A93040CACA10BB9C30234055028D870A280540BA477B85075F194017D3012DE3A93B40E71CB6C1C3284240448B203FFC10334057BA824EB1D218406A91C4C18E922C40E5F5A1C2E30B40409E416F123B015040B576E8B6FBEF3E40F0F9EA36E6F60740BB9155B27B691D403FF95810F1EB4540C7C0B84605FF4340C5C8E9EEF9F32A40A050BC86216DEF3F161E56F79DD40F4018449505AEDC2F403A55F58418972F408E68AEA8F11C1F4005C6E32D492C0340D280E0C558FA1440D944D8FD71D1234056ED2CF13E432E4085895DB8D7771D4003DB3669C9110240316A62AE97FF0B407AD2B24D48442B40AF5BB080F9EC31401237E1A565351840908173615FE012401A0CE21C9D642240E21224D251144540E7CB3498F6634640B4FDE01150A92B40DBEA0ED0BF6C0E40ACBB903829B32440B23670B10DAD4540539CAD45D2A946401C6218D4D5303240DC9B68AAADC10E40434BFA8607242440D867AA6F26194240EA4710DE98D54540538D172AB81930405F308313AB361540DF20E36528CA284013E14BBEF4CA4840960F1A2D60A54C40CD4B841ECA2133405C7F3605C77C2340ADCCCC1273D63240FB764CC01E5F51406088BA5DD02D5A40B3DD338225E94540</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id="72">6E000000E9027D4E56222540DD1D5C52180D4740DC27F7599DA9474066D886A795F5494087F2FA90D98C3740F4F2B2F337A02140339882E110FE3540722AA4439E6C414003A25B3AC70A47401BF976055C973B40ECBA99D0BCD91D400E0F72212CCA33400765E2C1845D41400191C78129394240A78CE059B898314035FC5177BF4A1B4011F246707B9335407496B58B482D404058C512837E664240A87D7AD09BB3304007325F9477BD0C40440A5C36C3EA3040FC3531131C8437408EFC915D183440403FC9DA6DBD903140B6E268F04B551040365FA31110032E4063EDF9087E023740C622EC2ED872464048F03DE8ED464240D0EEAD29E8871F40287ED9DFE19E2B4069CE1B6BE62B3740504F3F0281CC44408BA80A7046AF374016E6361788C40940C5CED5618075204019A00B1B866D3640EA816BDA99CF3F4073A59DFF0FFC2F408E447E11D368FE3F5D19112F41FC144016CAF5BD001C23401B4585C9925B2F40244FFC1F7E792340CC1EE17C92B909409AC4AD5B181F244091190AF966592740E52F4477C1A23340726D0CBB87802440CA067BCE080CFD3FF40C6890DEBC12409F0A7F93E83E2040D090C9D371022C4058EDBCB97BCF2140319DDD8F3B7A0A404EFB969453341740C43B26E37EFF2940BEC583CC7BCE3840FC7E39B774383540B093558B13621F40A56780B5EE163140A108FD85BAF6394088E9E32938B74F40DF44F0E827904A40BEF79EAE933A0540B2E6C537CA69224023C9ACCF4FB449405862D600DDCB474019D51D6BEA4630407E7526ED7ABCF93F39E500FD556C1E40031F1D2409773340221D638F6D2133400A48326DE15A2140B652151282640740F994517CEFAC2C403305133CC9432C40D50778810D522F4045AEC95B46511F4047898DE603AF0240096EE0264D0D2140DA9711A29C38224097EC0DDB99DC2640E32C913BA3EB1940497D45AB64AE1340070CBAC72ADA2040E23E6074FE8D2F40306B0E7CBD783A4056982576F3902F40BB2F075632CE0F40984EFABF34EF2640E08EB0CCF2FF464059119730367048409DCD4457923C314004992CDE339F1040B530D57CA97F2A40D9BC661842A83B405D02BB1BA9A342402A5493E789832D40C9F3140466271440996F4C6034D32840F7CCF2A721973840DA9E4D9F2B97434023C04DCA62163240422B9D8B7434234004173BD37EB63540C8A4FAF3A2804D408C5F3E4A8D2C5A40703A8052C5E24540</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id="76">6E00000057F6455D162E17405AF57C5E37D2354083FCE13F841241400FC8A531AEC84140ED363D933A0A3840B94B6B5E2C3713400668FEB3201A2440EAF4EEEBA42441405582C57202724640190715AC92DA3540B852E883603F0B40C5B1612B857E2140EA858EF892403E40FA0BEF07447B3F40854562F3222F2E40255A67E849010E40C3814BC5814B2E40920D3594D12D3A402FAC368A30C43C406C570A0A55F030407D3A69B5CEB712406512A32B01252240AE77A57C5BC23440286D5B7127003F40029C6170697033400508D36243BF184049B34793A6AA284058451E8C9C313940054CA7F7D99647402DEA83C089953F409A25984803DC19404FC2B76D93663040BE8FA2C54DB3374073B3645C9DB34540ECD6E7DE3C033740A8A27D6FF5C30540C3FD03E2FE5E11408492E76F8DC3354006C958606E1F3D407E7C50AE29E52A406D3C745DFD34FF3FA538D191E0E205409AB85E43A45F274089FD24F67A203140CEBFB4FBBF00204022B336354CD30E409B92E676420E1F40DA3C259360F521400D6933976A6F2B40E786A366D2BA204083CEEE7CD63E0540418570EEA85612403D14AD34B7521C40B061B04D42EE2E40E86BE0D1D0A62040E1CBE2DCECD50D400DA5169840672040B0116603665A294035D9D5C6401E404022D3334041BC3240BC0FE8D1FA412140A1504B214DFB2C40649A0D53BAF738405F397823C265514037A243B99E9E4940042D09A3074B0E40D137249E681119404281BF0E01AB4140E8C25D15F52B4540A000117486413140DE9BF5D448B1FF3FFF782D8F7B0E1340CF634C46366F2D40A0A1D8B0F9803140E14957C2226B2040372110D5D29F034083A9E2281C511B40D318F5EE090E2840D5C3393BFFD427402F5072A1B8A52040410F48423D72FB3F39F393CF98E61440758B2C5C6CB72640A4B2784DE2C22A40DCEC1D6EF5AF154091E3D9FEC5AE0D40AA8063E1177221407EDCE84BA0543540AD5574B0376A4240601F14FAA30C2E40CF356C1A33E017408B2C43BAD62C24407893E3D3B42A4640390AB81BA0014740052782D2D6683340275B6F3A57BE1440F4E6B6A4CD6D2040BCF8B14F69B8434069F7B98D9BDC4040343618E5D9602E4054DAC8E2E14B1940E50AABAAEF351D4023FE06A63F05444033740586D15845405911C6DF1E0D32408785A17A56072B40CBA8CA73FD93324080879E33C73A53400D5220D2471758409664A5599B8A4440</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id="103">6E00000039A30972A0701A40006AB7EA03F63140935D33E141974440CD376467B0564640ECF6045BA8793740D775EFC74863064085E39044746F2240D5B8490F27FF42400E23B9EDAFBC4140BB9F25EB04663840E682650191A00D4029F59E8B20B2204018450FD4BCD440405A7D0B5156233E40794E47A2EDB032403B4E598E85E910408272857008D7274012859D31DEA04240DA7D4173A1A34240EA9105C2DD743140528263CFD2FE04406FC98299CECA204056B9C2FFC3AE3A404E2BD7BE7CB3404063E855536A3A35400CFE046683C20740578CF6C1E82F1F40B90DC26C1480374059D9E90C97FB4340775520E7A09640403E6B6F7747A51740230B91BB9A1424408F018935D00F3A401A7D30B77A2A47400461E8765AA93A40BE91413838EDFC3F378EB631CD8F1240FBEF0144A7E63340B39D3D16BC96374017ACF3FE7F7D2C4046C6B3AA0F2100408EAE8B43E5DC0B40AA923DBC03B4224019CC4540DE062740759B991F6E6F214038E6DF3A6A951540C3B520F54365144097AE145FC0742640AFB300580DDF2A40636E5BD45D18214033A9127BB07D0440D65D27DAB33D0D4063B76C144688234024356AB30BEA2C4037922E6F303F2440687EC63E254C0240D96D9613DF050F407FF1CEB2BEBF2240D60F290194663440FA0A222F80133040462E7A32A28618400EA24E43CEBE1B4024927CDCFFDA2E40161F595CF0B94440F595C507A4EB3C4052648F07451A0840D25593F3BFBF184059FB7DDAB1DD48408FCBA175160E444004E587F4AE842F408C742F1A2C54F53F78E76145DA550940944E68A04C562E4007A8675DF95A2F40B5AE83424C902040FAD7A9B4C85D0440E5FB900713E512401FF29C837D0221402D8FE5B78B3D28406E0E0088038E1E40F3E3A72B4BD7F83F5583D22F7DF31240C83C2A32B8401B407553CF6AC84022408D065AB20E841740412C8D51C652F93F0F6819D65C9B194016B348EA31A12840A48FC5AD954A3640C9755193E7252B407188AAA8785E0F40462717B0833B1A40F1CDF04B71CC4E409D72AB77C2EB4940FEEC02775AD333407BF5B75FBABA08405633F22A17AF1C409F9D90081A0142404F18C6CC588A4140D09C3545C61E3140EEDD3DCF1C7E0B4088EB2EACB7AD2240E22D19633B7A3C4024A951EA91B2424003C8EAF290123640CCEC4D9FC4362740B01CE78B75582E40DD0C8A6C118A5140E9D90E6708FE56408B09BA2402274840</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id="104">6E000000844713712D671E403CF4038C782A2A40A0DD5D2F77EB3040FF4DBDC0A08F4140217E611ED1CD37403B2C5C8EC9381640EC156A31B8111440737D41DD385925404A4FA889D2C6434077962B2BA1FA32409E98D15F6EA91240A0C6F85B7CC216404F2680B33A2D2440AA686E262EBE4040C89B32D0BE80314047DB36C0EC7E1640A23E041010282140F7EC784242E726409AB69B7F6C5E38402C89C0B46F963240D6D3684D36F107400A291EC9A7F6214016D0224667282A40D81B0E78A62F39409B3B1F179CE13240894B14E6A81C12400AD6B20ACF57204014336B3B3B9C2E400E074DCAD53D4440A0F4A7486A7340409BD6CFCEB86A1040C1875184BCC4274044FDC253B826334092690AC13DA84840D9A91598E7A33940FA241DD4629D02409E11BEE1999B1040D81CF8A1DFB02440869FEE70F73A3B40861A13CD9E1F274046FC01762522004037AE8EBA4E860440AC7861B90A781440160E4BE8F75B31404F2A8851E6EA2140AD9BFA9B26240D4022E873AE250D1A40E2D5C7B72675184055B777B4921E27404C10427063651F408C45DA5229D2F93FA8429365C79E1440CBA1D3F1B64B1C4032C60E113F732A40A2C03496F3991E404364B3FC40FB05405DE6FE2A8A3A1240B46709CF90982C402D2B2A3B81473D4090D719061AE9314096A1E4B8B12C224051121679538B2340531FEA06431C3C404FADCEB8EF844E402726491737CE3D408ECA7B7AB4C7064091170AAC74C31F408F186E0A490D3540AD0B7DA1BBF04040A0BB4613BE962D4025E0FFFB4A5EFF3F7E07611D72850640002CD4C8BE202140660056F449552B402DF68DDB58C52040C8F4A5D43870074082E7F07BFEBB0D409DBB89B2B336184049EF75B766E0254035335649B6A91B407E0FAA44BDB9FB3FE9B4E7EF9B7B0140D30619425E45144062F607E5F3F4264017334F35D02618407851E6C7858E0B40968D0D641D001240416CD09016623140593AB68BF4D03E40207E52183AED2B40E391E7E9974B1640B9C11E5224202340E2290906A8553B40D5DFA82DBCC54240A1F2FD92243432409231AE19920517406E957024CE021A401845263955392F4021F4A23E95DE3B40B76B2043EF47304081E9541B13C01440CEE3C83837E81940F9441453C8B43140CBF33A3473B64140B903C5B5CF683440DFD13194186429400D1FBEB0B3603040AE452880CEE94240B205EDC1B84A55400FBDA49E53714840</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id="106">6E0000001CA93A2FB53B2340802969D2CCDE3140B396CFB284D943408E859CA1F55344409C72F3D7B5913B40714EA06CB4171240C1D3F3E930DD2940CD1EAF68D2013B4057F6779787DE4740A49203144FD13B40509F28A54E9914403B08E02C6C0423408A10BBE08D033B40A2381D3DBAAA41409A36CC5127CE32408DA530585C591640339994DDEC1825403CE0F6DAA2AF4040532B7F3409A142402C2183F9083C3640FCBF4872479418407D5792D88FC02140D9BA08FA486B3840E88D3A6380CC394049BF6222FBC93A4025103305EA9D1C40D60020215FA92740271076D665563A405138A04716444540373F29CCEDB74740A869C0517B3118405192F4D77B9A1C40BC51660A26A83940E5E7BEC859B34640460B43AA72F4394074B7B94B0AA409404914F1E290F918400462065810F42A4019971157A4513A40185A8A8281F62E4098024188543C03409420D68C7F280F40693D574A9F0D194042AC281635EE3040C1DDD5DBD7032140E0A38E8B8E990D40F823DF2A2B4E1340836616EBDE4B2540247EB00D1DE53040E5537E85EC622340717E83B46C330040941D5AC7EF850E4047FD068FAE862540EC5939DB101A2840B31B69F893BF2540C4CF717B73E50340C2530D66928111409C6AEF286D552C405D8509E543383840A09118DF92503240898C894DDD4C18402836FCA9D1EC204062D9D8A8128F3640F8C047A267954740CB7919C612E74140FA1EEBD8EFA30F4000ED097136931840347D5BC423D942401F95210B426A4240360CA68A8AE430404629817597A8034004CDB1D55C3B124013D6F620B0212F403D32939A45B630405C053A1CB55A214099A5ADC240220340DDB6D7E6E4F71840901886DC91E8204051AFB75AED5028403496519FA6DF214099FDCDF28FFBF43F81F7D33F71591640545403443C2521400B25399F54232B40B8FE013A71151E405D29615ADBD008407E1BC1C5DF391D4094E5B9105FAE2C40EAFE696A99703E4081E7353FA11030403C0C1F99A79E16407BA02F74ED442440D563D2D4E1134F406E6A35ECB65C4840F9DEA08507613440B8242C1F35CC1140D07EB3C0D0CE2240F58D43735A3F4540F62BFC78A3764340E91AB863211833402EED76FCC2051640EC70C1F164242240F7F320F95C5E3E4034048EACF11848403AD568E2DD8F3840BD71217B7E1A264041D29E8AE156304041F0BF2468EE534093B6C79E3B945C40E7B89B698DC24B40</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id="112">6E0000004F1881C5898B2D405653F3E080EB3F4037CC09B9401540408400581E4B614340077EF2A72BA038403455D37C389B304086C41B29E8C52E4091A47DA68E7A3640FA81D8BE609941400741BC79D7C6344067363D936F151D4045CA49DBA36934405D1A16EF71393940C6D8CC1A5F343B40423401A6C7712D40720D798AAD92184052FDFACE6B963640074D554A5C1F3A4005CEE03642ED3B40F518AC1BCF7B354035559652411517405CB8A74DD3D932409A79C98423233240AC9AFFDAEBF638406F06FF16132D38402DFADA9C8A0D2340A6101735177433405A519710CBF4374000505D0445EF45406E7EB1BFAC6C4440E03EB4D7C2F037404887523DE6833640E455C4167D533140D56943F4BFDA4A40D827831CBA4241409E1E1EDCB25020408BA1AD65FA4D234091A499CEF9942340A62EA533821936407A81AA091D742C400DCAFDDAF67011400752301692191A40C5FA5827780A2240B413ED2BA261304016122362D31722402E2AED0D6C47184075D80A7037BC2540A54869607C2F274020CCB34BCCFE2C4060F5370047B22340CD00219CC6270D401286A69AE50A19408F72FD99C6C11C40511B83937A2229401F36E1F61C192640B666652EB7431B4073ADE52B92B82340578C71D13EE22D40A4EF104F3F903E40F4480C8AD0BF324012271D1C199236402021019DDED536407B412F9D8D3C43409E0CA70EF8C05140A0CAB1A7BEE74B400D41F599E0020F40177A168BE7FE2540F888562C447A2C406EF90C7C782C3A407A545CF1EDC12F402BAAE13901760040CA6E4095BD441240E505BC538D921F40A9DF659053AC2B406C3A0CD6C1FE214069BAEAD30C2205408D8FBF6D4FF81340F4598F85584C1B40FA9E5071CDAA244091B8ECEDA76A1B40E202418606CF05404A4B7AA50D61124083873D69AF5C1640F2018A9842F82440D25A22C8B12318406FA4207A253A1D40FF27066AE6652840BDCBFA48728B30405E67C266BB323B404EEC82585A5A2C40BA8C9F1A73731140112B80D5B23C32403BC48A8094B53E400BB80597AF404340B7518BDF09A33140A4D91E21C64A1340195847197084304085458763F2883B40B9DB600A3C983D4094DD5F5088422F402CF3CCFFF91821407A3EF25672823240DE0B7881BD8B4040D66AA763B97642403707D0E73C6534406E3149D9436A3140AB328542FC064A402FBD57F22A8B544097B99ECF9A4A5940F341F5081F384740</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id="118">6E000000B5DC222B15BB2040BD4785D297401F40BC73012E3B3F3A40B7A0E31756E942402DD8399BD27C3A402D840A0A1FF9194041FD59AED7472640E838101392C83640D75ABE9A98DA414012AD5AFCA9533B40CADDDBED27B113403F65B8B72DEF2040211E20AC03D033403BF4EBF7B8373B4008ED4F4373243340388831DFAB901040904C119BFA58244087A4F2E3225D3440474C10CD98B73B409D699067E1113240293F1C5F44800440023D97EAC5672040C1850DB5AD803540A2C371BFE12E3C40338100D5A4343440E536CDA0CB701040AC91DA541A9B294026D4634DB1403A407AD14107D4D14440E028FA16543E4440B5BA805C38D31C40C7C7D9BF943D3040450A1CD5D1A53B40A195DCD947274F40E19EAD3BB1E24240648CC524BD190640D6C99DC119701540E532BA69D2D129408A6FBFBD337F3940582694532A002D4076EC1DB97D17FB3F7BF14E244EF3074046D8E2DE5DF21C40B4AFFC3FAA2E294090D5B94741AC214086A8BD945C820C40F463A6D4CA4B1B40303ECC74EB002040E669BB95D37D2B401D04D05931C51E40C4355A7F5B1A0340CBC6297BDE2E14403D60F6FB05D31E40D9D92D25C3602940C11801CF4DDA21403DD3551D0B580D40E3436B32D5C12040094ECF2CEFD6284088359F4F843E3A404756EFDD41BD3340CF625FA61D452440BCA21B85776C3040781B71CF59CD39407DE59B876AAF53400306B163D1624B40BDF3DC0C92510540B73F3CDC6A74204060B7CAB4947F3240806CE2F32BD23D401F3EB9D51BCB304032B9817C75B0FD3F56444EEAEB231340AC19596C779529400EE1EA9CF40B2B40831CC1FF0C752040C85ADFF820980440178B6123519715405375B8047DA42E40456E4BAF449C2E407F18F3819A0D204028F80623F4CF00403EC0D0F61D8E0D40B113E9E869AD23404A5EFA5DCC532940C9D889A21A191B40DD2D8B5A14FB0B407293446729A31A40291D333F708C30405AA24F98FD613A4000A62F8226022C40C3B23EA4A80A0340242C578F3DD22740AAC2FB6679FB4440A6FE418A0F5A444088E629EF7764344079B913411C410940CFF4740B0C842540DA4E77969FEB4540B1C03BE6C3914340F6B90F7C37983340273B223F78F60940D8D1FA2468D81C400137ED0857A74440F471F68811A148404CAEF4F654133A405BF31FEE5C301240F6F66BE1D7CD3040F20F6D6BA08B4F405ACA20654FCE554050066DED56C64840</Trial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Left - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id="161">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</Trial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id="194">6E00000068FF2B5B06CA1F403D3E193A41392840F5CEA3B7F5BF2A40A8F52856E5CE4540B1F440D6B75043407BE26D4478061640DD0DE3108A901E407A535644FD542B40C9FCFC26DC8A45406FC8BA56437E38402F65500470B00E408DBE429E85FD1F407D133FC6B8092640128E244BAE543F4041FE9202625F364045ED23037CEE17403BA919E8937F2640B6075089868F2840036AF676DFF1404089A3A12605E63B40A156F800F24715402B34ECB58A112440781B29B2373D2940BA51EA0371DC3F40B3991109E7D13C40277F78767BFA2040D67C47A9B6CC2540EE6DDBF594523040169ABA4CB568454092DC221C86C94440287BA9AAC6A32540D276F5201B8B2D40B19EC92EFA72304029F584E6587D4540F926BA7E9DDC3E4092EF37B22E720E404356987AA469164025E5CD4EB14A1D408F3AB9A508B43940CF8B30E41B092E40B0622DA58A570140DB9028C354BD1340F9EDBF29219D16403B834B29D0582D401A91F23C92B4224021E23B96D57F0940182C7041F139154012BB6C1064E81E40D6492EF8477D3040426128A79CCD23408C56381C582103402021FFEC53460840F527B3ACD3F61540076095DBB3502F4012DA4F29E9FB29405A41964735701240D41062D7C4D91340D3DF0A7AFF9E2340FD8BC073EEDF3E408DDCD07320263440B3F98B33D83F2A40C361C78FAE1C2940B4875C3DBE943340D29C9C51DB364C40C3BEF53715A33F406068984CA34A0E40A6FBB4F7F81A1B408D108E9749262140792BE4D79F0B3C401A412A6C62F933401F5C87BB90AD014021DFC8516C370E4039EF46E8D028154070BB2B552C7A28400C56681048432340AF2D31D9AF720340276EE65EA8D40B40915BEAFFE7401C4032B09D1F3A6D2740E23B08AC3DA321403AA91F0644F20440D6A1F71662600540E9BD78DA9C24124034BE01CF45723040A31B7126271C1D40FCF4B20209EA1340BE1B9700DA0718403F61800DF5D226407973EC3D42584540F168F237AD66304079321A19BD9F1640F92BEB7BF56A2240CCCF90F0B6E22E40624E4DF227BF41407BD4A8192A003840C9264B46C11613407CF65E20A62C2240C6709A2EB7C42E40D0E37AE3CA434240E45C0AE859073540BD599B558D8C1340766FB753B918254012200F19848B34401BDD6A5E7FFF4940EEEE9E3C552B3A40BF581A1D01162E409AE46F4B92BB394007B6A8E9F6714A4014E860A0BB4F5B4030AD8F3B35C64E40</Trial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id="195">6E00000017261A36B0F7254075560F71E320334099D7DA4C91884A40610A27D0BDA9484027453F2FC1643940982650509A4F204052D0C64D7E502740BB510E7F254F42400788BF03EFE34B40C69F0F3CA38D3740DC2D7CBBF2C21A40EA72990FF66F26409ACFB9E90E0E44401AF90DE173B94440450B4A5BB0FB30403B4A853577CC1540CE9D577868BF2C408AD6CCD14F86494042B2A177216E46406D817CDEADCE3340D5B5A0040DFE08402939B1DE918C2840527E2A8F211C4440E2024C564CED434075729B7683AA344091BA32ED56850F405C80EED510A02B40DF45AF72C38A3B40924D7268EEF54840A10F6193FE7C3F40B08AB8D78C221A40ABC23F55C59A2D402351FC764DB64140676843C407254D40129E4B2B8DD83D401E9976DF96A50440796AB0CEB2BE1B402DE531B985DE3540541DEBEFAF68414062646A4B27543040D46194709CD4FE3F0F79725C9EDC1240D7419FA9A9B631402BF0EAEEDCA136402CD9D4CE72622440C4A9268BDE0BFF3FBAE6DFB379EA184032BDBD6CC5623740D23B91AD8E3D3340EF2B59C495672440AC085A85C407F73F135C88A086C01240AF4A8A87878E2E40AF0CE6E460413640647DB6F88C6829402375B1977FF90840AECFBE6015BF204084F81A3F42634640907E518B8DF04840D0B50BE6DC6E3640FC3D2F8B50A31F407F92A09B250B314036534F81C88952407A21EB9D8B735240036E42C2110C3E4042F81D3A41510340E30151D9CB4822401F6FABA983B73F4048B4AAC867FD41407B5311D8E9223240F5278E3C0067FB3F4F8F41F143A71040CFF38600C5502B405B761A25FF923240DBF760AED8FF2240D97675495E4D0040DFD09CCEF3301140013A5075AC102A400B63047490242F40A556A4F5B4C92040103630968522034048ADED9296B812409EC50AC29E7139403EEEC462A1C4384029A7AAD621B01D40D8B30F2847891040F137227B0C312740E34EF396237459400B7FD25FCB675240FBBE058778DB30400C7BF71238551340D19403EE0CB221409DE96D14A99A4040243323954C724840E8B065D9B68034403BE0F9D94E8E1440D1FA7931F2C62040A9F9B7B3121E44403D55A60E12C24A40B458DBB7CD4832406FA30751C5BE174049876D1897722840EE5FEB3B371C52409255FA6EFFE35140B4FDCC625324374011F47E159E302A40BA12CEFD345235403A2CBE0B2F325740DE5A5867F25F6040BA4B8C09B1A34A40</Trial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id="203">6E000000A231E83785DB314041D8D70CCEAC36408D52F48C2C323A4092EF5653EEC6454051251A8DCA5B3A40046DC81487EE154004B1153C33F125402515EE56AA433040D84262D1C36642400ABD8854BCEF3940C6AFA28B6C720B407C73BA864B7F264084EB2A07F9172A404392DC7C92193940A176C7D342292E408F759B09C9260E403CAE8002EAD42F40EC19817641A03140526DBE98419F3A4030D1EADBA3253340DCC95C5E5A390E409678810492B32840D42F1B61C14430408562A24A38323D40CEE2FBD1C6AF3840A3837E69ED721C403AD3DEEAF98C2940A0AE4D0CDE763040145039020DFF41401695BE12C01F444093854BE9D0122440A14A1F93945327407B2A0F23A1704040CDE2F614FBFC4A40A2C82DE1230E424007F0C3AD5E6B0C40E09F420C26771E40BFD2A91A78742F4087453FAC667B374073F685C94D3B2D4023DE2A64EC81024024F3836CD8B0134074BB806994911540279784B51BC329400C366AA64E731D403C609291CBFB0E40AF4E9A416A2A2140E99C0288682120405C304D0410BC2940CDBF59A3702520408C1747C245E60340B03FEC41288D1140DE828CF98AE121403DF8781EA2D62B40BD5BA583C7752240A57DBA70295F1040C322750AD2231840D6A2F2C33C282F404BD85715721038400E322E5DA36B2940389414FD12921C40334ED4E81D8A3040EE6CE5C3B535404067212FF61B4A48408B81220EEAE23B40F84585DE48CD0C400A0E70E641EF2040098EBEAA25213A40C6319434B2253C4058E81E276C2E2B40B049953AFAD6FE3F67F610FB753411400F085B4D8E092440290585CC19E62C407B236DC4DA451B40A4FF89432B0707404220E78E8E151240D0DCE1986B6F224046A8D013F11D2C408D6F4C9FD01A204020A8B17D1C110040111DEBF4698C1340124FCF9AB0BB274069A44EB4C5A62D40EEBF5C941CFC154008D143E1CB3009405B7566C6E2142340E21B315655373740CDC31DD4C91C41407A4A209157612740ADAA1FFD0ECF0C402800D90DDE3E25408784FC4F11923B40220AA1195159424072FCF867D5D63040732124B46D910740C17F01EB2A092640A29CFBD9087D30406EDE3177B7BB3F400CE03CEADA4C3040460FC4E09EA40840DF1341B204DB2A40264A4D49F05C35407F15379B1CFC46406D10D289C9403740E1F573A9AE6121404E225EDEE77D3640EF3A4FBC6E924240D46644E16C2E564006DAD2F5A0134940</Trial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id="208">6E000000246888E71A91124066BB967ADCF133405300B35701554140AC1EA0B6EC9F484085CA595B95A83740216F095025331C405C2CF23F554C2740CAF20B1D46D73540D008A03BE1364340FD47399C66613540B8183A856EDD064041A66811B69A24400CDA2E29871F354046E73F806C7A4040F373045D52A82C40B5D25FE09F60054025453C782CF426402970E4A61752364062E15B37663A44400572791051BA32400D18A559963F034022C1212CF466234007AFFDFD63573340C195C3A5A1D9404082298BE7832B3240C2C07D2F1E890C40D859C8548D602D40B65517435BB137407E27A9BE0934484018F1FF574DFC39405192566CEB8C1A40DE630C12BB8E2A4055FC96BD73783B407FC6BCF8B0814840734D08036BBD3940D9050B12AFE7034067968EE7639D1740F191DEEE954D2940D2A21F1951323640BA81B43490C32940F7BEFD58944FF73FCC71E3E8A5E11240E2503EA4526223406D1A7892D5FF2840FD4016019B9C1A40F0ED9C5D592C0D405430DD6F78A21940A208CA4DAB322540E140FB80BED32D403645D49C65B91D407E41FD284F06FF3FBECBA3BDB7500F4055004EAF29C41E40DD249BF33D292D4020CC51A8F1522140989591FC2C510040E8707DC0F99F1E406D5460E230AF304042E1F23F1B363E4055FE7242B53E2E40A605D3F8B4811140E39A3830EFEB30405AEA62410DC6424032CC79CF4F965140F9F9B6CFBC714440D5CAD3310FE7FA3F24442DB77FB31940165444AC4D292A409BDC25F6A67D3840F4763C1C28E72940A7349D4445EEF83F1A93A459C0FF194039768F4479562040678B28A07F7625407FBCA29C12E51C406AD218B15F270A40D866236BDDE61C400C412FCE017E2740319661B217832D406494605E14FF1E40601E221EE4060040007C780849FC1940C740B954CA972C409E52146692BD2F40E8879F77F80017401B7711039C770240D74508DD927825400D0C637AEC763D40797A596E84B74140DA258D34C2DD2740C37AED2B5CB90440B3EE35CCBDEF2040D7769996490D34407C1AB6DC98984140D91D900E534A3040092D64C5BB7106400F7080F9F1B3254037EBBD46F7F13B40AEAC1998D0B14240D8E57830EF9F2F402EA69A6163160740E8B734C4B0C82A4037BED12A8DB04440137FBC9DD396484064E2F16FD12732404BD3C59B6A4F2240056E450FCF282D402328C131D71C5040E255B898C55B5A4098CDDEE3FD934440</Trial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id="211">6E000000A7164740BCBC18409CB72DAC1ABF2E401404A8ADB9E433407ACA15F1974141400757DD9ED1F93740B7944A596C5317409FD8500933E32B40163725CC81422F4055840853721A4240E42B0A942E7F3540B8EAB8066C101540787BABBC99DD2A40CB5A50CEBECD2B4077E0E03C62983840A28358D695642C400091F1C180D01540BC2F4101A6CC2640A292C3CC5D1F30403DABD6C084573A40A5590660F7163240E57BF187E1DF0D40D57D84CC6D802140B7314EB471B72B405CEAD0C8D3C93B40EE89C1DF55953440D481EDFCA39A15400953B8AC712B2A40A41110992A613140E174304F097A42408D01B1261DB040402B187E7AD8CB1440CF255173D27A2E4051FD666AE026334050CF3FD2B75246407C1B68BE21D63940057FC710A27E0A40AA2171865AC82040BF8288160ADA2440C81D4FB79F6A37405E3CFB5FF7542B40AA8090BC40C1FF3F5B2547670080154047DB48F81101174076B9912900A62B4001AE4058F1B71F40B06AA7464FC2FD3FF8B5EB6D69031240337FC326217C1C40D1179EF1A5222D40D85C79C4047E1E40389DD34B1823FD3FDB6EF8ED1C270E402D8DA6B49059174007427ECB620A314091BCDA095EE224404E66350B0BF209408AF8EB376FB91F402092CF7E03352740BC1992452B2F3D407B4DA5B4E6E231407BC74AC6A2921D4071F16B1064822940433420439B583A40F9BF5DD4FA885040B74F927BFDAC434066FF9589F3380F4068AE6BDB90822040099CCF5905DE2940EFE9CE2498533C402EE08EB3E2603140F75D2B2FBE3EFF3F147D2993A06B1640926BC59BD0F5194036DEB82CCFEB2640021ABB9F2B892040E57CA42DEB670140DBECD4B0F64D1840B40068CFCB291F406D6CAC5BC4382440DAACE597BB1F1E40E703C2BC5008FD3F48597387747F1240ED02BCCD0C4F214001B9BAA2652F2B40750BF1B3717417401CADA1C1365B0C4075594DEB770820400F1E71167AE03140244D01806BB54040A1B1CC6891662A4057BC05339B65144029B10A651BF023402317E7E45D7832401B7058A5E4A63B40C3FFEBEC38342F400F652050D44110401B2A114DADE91F4027C4F25F5C1D3240C7BED42BE2313940BAC8DC36B7462D4055D975A163D90C40533C63A2136A214030A2FAB689783640436FDEE4FF9541400D32DFA579253140D1D709C7F0CD2640A5A7A4FB119332405A63CECDB9F04340127ABED72CAA55400136E1226AE54440</Trial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Right - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="221">6E000000860AEF8D0D383240688DD383295B4040B05B289E85F346404CE8877A41EA4940E4B44BD22F1D3D40A3ADEB66551D1E400469AD4F531B31405EC6EBD30B1A3C40582B35305D9A4740FE6B2AA00FDD38409E711A20AB7C1B404C0EFEC7CAE02F40BAC919F07CFF42400CC53C5FE72D45406A4945847EB135409A4399D3F2092240B351E80ACD313440226993419E0943408E5610B4A05A474082D2C32F151635406CDEC48890D31C40442B2F6D02C930403D7CD8CF65A63840EC9B179551DE414085A5CDEB260138406DF7AA034EAF2140C74898328CDB2F402B75025899C53540295243BAEE84454028A6BAE843D04040387F6A8001951A407C75AEF64DFB2640D5E53D8D0CEA35406DCEA8E4507A4840B2D54943041C4040A1651CBBBC280640E70F796A7BC91640F2AD93AF3B1F3840146CCC4249784040655C2D60BBCF30400202C2B7885CFD3F74F89E49810D1140EFDA40DB6C7A2D40E141D251F0F03640738F1EA6E0DF2740A0D669259EC00A4004ABEAC4E3C21A4061704285CC312E405224B910B31B3840DF93FC43180826402005726A176CFD3FC35550ACE21413403F889D7181B22540ED8AD8A3E8BD35406C2DC8983C792C40F43444CE96C208407F06815EB6721140913D4C84030639409902B010FA9C464006728866B3683840EFD6D6BA49A32440BA82D0377DAA1F405B363B89E1CA3940A08D01383EF35440FD6850B85C204940083FFCE86D2113407E2EB6BB25DA234046DC201B1BF650405ADDBEEDFDDB48407F6528A8E84E35401F2BF6F421F70540AB883E5E13211740A50D4142CECB39407F965CF3695439402B2E531FAAAF254090BB6C0685100F40AFDAB3E25EC41D40020D07C54E742340E13365E987F12E407B2E2C25D76823406D2F5B49D99CFE3F0AE6ADC9147F12401EFA84DAB0AF2440C0C3571251333040EA95A35168131C4048EFC6A138E10840935EF12091B51B40C7B897CD1BC0434041C6E28392EB494025F38769CC903140EC1CE13DE18C24404BA093E6166F30406C433A326E324C40A1809D55C45047402DAA9C15D83C344024E10E2B4E652340057EAB038BE92C40EA36B558BA313A4062F5505FDEC94040CF2D0C6CAC6E31407DBC141484222040F9CE239A99192C4088A44C6649263D40B12DCC4FE87545409AFCBE48D26635404E51AC69B364364018174C32109E4040FBE6E6CA29394D40E3ADC87736625740DFBB9CB58F1D4B40</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="225">6E000000A4E666A5643121405F876DD0008A38406505A3A412B856404AE6E1F4934D5340E15084D8458D3D40889DCABE21D8124007FE00CCBDA030408683F3291D1852405A0B39B4C22C4B400ADDFAB8AEA23940DA70717543CF06400E0F31BCB97B2F40F8509C4D14935440A3B78878070E4C40E4F13C3383343440FF381A48863A1C408C395D18B57F32406309819981095440DE019B8416B14B405791275C5DA833406E3188D974E317400D52D426FB6C2A40DEF6CECADE114640E77D8C22FF72494075D88AE7BDCE3640176F3B824564144061374A6F576C2840A5376553277B3F406E01630833AB4B40A8FD9093E0863F40DA1F184A891D24407945C9B765672C4008F05BEAC32F3B400AA12F463CD64940556E54049E464240DCD4325A95CD104062E2E48AF4CD1D40F815808435044840FEDB799A0510464088D9EE5752D7344004CC91F50C6F0040388B65CC5BCD1540F779E05C19894340A8376068ACAF3E406783B44AD73D2840685F44F2C74D15408B7F18883B332240EDCA8D4B432B4240F852F726D2663B40EDC5B07CF8572A40B3FDC9DFF93C07407E028BA842091140121CB6E0C7EC2440AD81408E35773340D95D5CD96D032940832E73842A380640575FF1F553AE1C4002ACC5CDDD4B4B40212B22C816A24D4092614C4E51D83640111BD5BD2C811A405AAB618EEB1B3040F535342F0CE25540FEDB78EB9E8B5D40A9B0954B0661494092A8176115FB11408283C4B088241D40A09129D95C1C5240607282F0F4194F401602AA1778E335406229971D0BE2F63FF69CFAFD6D800D40EA6F34F8B8383540B70A5CB629CF3740996ADE2831712440586D92B75B3400400364E4DCB43D1440B1505F5445D924408E15CB16AD433240D434CBA86E352840AD8C1B24FC36EF3F674E552DF3EE1040630DE34B1E6F3B40D97E38D532663640183238395B2A1E40C1CF14E072BB0240DCAEAC78A9962540F82495DE06A25D40F7EC95A6C3A85640F504AA781D2C3740372C7D300C3E1540D7E9D5D1AFEF2940A421FFC4A0BB4E40604BF2710AD94E401B10559098B03340D5613D7594330C409AFFADCE34CC28400AD07DBCF0CD4840C88FBDAEE58A4940FD4C814D5B4D3140792415D110240E401B0A1754EC9A2F4058725A51E8BF544030300023058D5140D49E63D15CA236407323607131823040788A98F68A543F40C7AB0F4A5D425C4071CDDAE298336140BF4B5FCDC47E4640</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="247">6E000000DBF86E86F8E82540E7CB648618AD344078A6A70553F948409E2D016D8A004E40AD492DF53278344049B3B9476F9717408727DC04819F2D40E11A81786D1F4640EEF2519C85B64D409EE7CA0C204032403B2F462CBEB1154033F020959C2A2B405D6AF8AF7A374640515593E0E756474041147BE152AB2A40832C963BE6601D40FAD72C4F94BC2F40B941141173764640E94B44CBD288454058E927E635F7294072ECEB98EA861940BE0D5B6BAC412740912F16B650D93C406423F0E7E4A94340A5C893F65FB72C407413C69631651F400C163183B0D429403CF0686F19F53A4081B6A84435E04840D7B103A07A8F34401DA5FD845636164050F629FA89462C4002CD0986A2CB49406FF410B73B745340A1428FDC96F538409D4C3F71219D01404EF19AEF08EC1A40B2E399D3FF1D444066323C739152454044AE19ADC91D2C40F47AEAC79120FB3F8C580197907B11409188FBFEC4C432401CEB858C48833340AA0259CAB72E1C40EF57904DC5380840902616A220BE1A401A50FE7ADF5232403DC80782BC073340DF10929F152820409CBD1E9AF6ADFE3FA9EA08BC884112401F13277FB5902A409C9E0783A66E31405E94AFC206FE1C407ECBE571B4940F405CAF52EB24441B40086F9F5516E03B401F1CE9D5E27E4440B99859747B992D409D92B1D6E82427405AE691131C092A40A371A246720A43404883DAC3C12F5340428200B572D9434037DA6791101811407B987A31955D1E40B95764AAB37A4F401B9FE7DBB3114B40AAE23D54035F2E40102CE27CCF380440DCDB250E18F60E404C42347673F4344076123B3F27703340FD779778581D1C4014C599F3729808408A4AE5CBCCFB19403954DF020D441F4020D3009F4F84294076AF1DA519ED1B40FD02F2249A14F93FF390848CA0811340F0E1DEFE33803140D8BF62F43EFB3340478758AF481017404143532F07D30F408479E7ADD6AA204007D31D700DBF4A40731D5519417F4D4029DD2585EE812B4016E38D62C8EA204076D7649A7B662A4071BA022E6C474B40ED5F425F3A144A404129C73A57002A40943E2C3173131C405227CBFF00AB294053DB62EB599E4340883391A9F7D74440FE431BCCBB892440FBFC780145EE174092B3D264DC3D2D40EDB60B37D676514001FD102F77434F402E71F9216ADD2B403B1F00CBFCDE2A404B9B6924697D3C4086E65230F3175A4024FFC0867DFB5C408E3DC297104A3D40</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="251">6E0000001727225B062F2E406943965303323840FB66A41E0E835440206C08DE99B34A4069823899D51F34403FAE041BA8EC24408CA7823D14AF214085DA2533EB5B4D40A6F94524B8804540F2A5608422013840E4152069B57A1640D756F14A430925401DCB0FCD18F850409986CD0B93AA4640DE863E44E86C30409CD78308235C1440BAADD327F74E3040164C15B3DC715240E48DA762A7C14740DFA39092A2B330400D19BE5216111240B0BA51992CEA2440FC925AF5B4F14A406C52F4C954AB44408C8F1DF3FCB53540C970DDC1A0911D403833255B8BFF2A400CBF20EF5CF83F40EF9827EF252543400FBA84C3BDC84340D84539907EA32740B3400FC762782840CB8FC4A557DE36401A89E0F295C24740657F461311973D40D0AFA17CDE191140BE67CFFE111D14408D5AB30C1C803E40DF1054C660B53F40AAF11BC30E153440DF8440E4F3FEFC3F78CC382724C81740744A0013EE323640B622A10AFD6C3540F4558C077A9624405C7D0256855F0B408BD796E511632940C39CFA2A74CD3D408E38DC6AAC3C3740B2C82012855523404AD2F60167F0024043391E20D449154098A6AF8581F632405AFDABEFB61534408F5ACDEDE12C28404358B7C6BAF71240DB5F208B98201A401D21F56736113A4062CADF5F2EA04240C5B0B9A4BF5E3840312D910AA7491C40474FFC5C3AB6314073E569E661B33F40A11A920737FF4D4005A17B16D70B434049B79DEB7E730C409AD28810ECE41A40515EE15DEE254A4014089D1DFA6045402ED9879690E93240EA3A2619EF6F0440B861D3BB1B7F0F4091A6D80D3DFC2F40BB8482F1646E2D4059EAE0F94A0E21402887D63AA5701040C857ED946F77174081122572C3C92340E320C342C7592B40737960EF186D1D40CB11051EAD870A40E224E1A32ADC0C4043D7F740BCF834404EED7FEEA23C33407DD5FF76C00B1A404D369F163CE21040A27F782F7D8F1C40782150C736AC50404254119298684E40A8B318E22AF73140484CB7F4A3871440251FA7F7D4FC26404438CD86F0CF514070CABD6A7B0D4A4007D0562CC21E3040D5CDC86DBF33134000C942546ADF2540889DD140E6E2504014739604078B4740133EF761CC0C2C403A27E9C348B31240704191D7A24F2540977B3B1D76A655407E7A62F8753D50409DF3FB26FE28334019145BE39C8721408C3A90733E913840B0CD6E2E804A62409F0A9CB07F6A6140C39E5333297C4940</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="257">6E000000240209F542B21140A020A07EA77F3540D9CDA38929E8504077B605DF29F250401853D2E3D57E384000241F52D068174028BC8C7A93A93040ACD449B76F5145409094023F1ABE494087F0AEE0AF803A400D787B31D2250B4071EA8C8809592E409B072547455C4B407AED6FCBFB194A40109FAA3569953240E6E7E617C21C124068EE87B61593254090632F31B8DB4C400D099828BFE94C40B9ECB67B78A232406DD5EF7786550740043548390B802340D365A51BEB8F454048103A12D592494048EEB417C0CF33405D80D657C61D10400EA0D6E5568E30401865B16574123B40097FDDB25F9F4740A55ABF11A6604140D1CA38C117AD25404F1960E436F529406CD4ACEC3829384012E17385D7054C40B7C7397EF0A44640369C336093790B4010B8E1B4872120401D2091083D47354003F32C3D31A43F4021F5660D43E33140CAB51DF06B4FFD3F239DACCD6A701A40C883A4B61D372F4097C4C1E43B0836403CBF2CAA04B7224049F567E93A5A1240B3D2E5932D261C40B38863DC90E1364062BB3198C4BD3640D47147281FEB2240C5013F30540A00405C571FFBFD390A408AF2B524D0CF2840691BEA0338D633405FF7726B230423405F92A45609920640C5C69D0A40B92040EFFF0609D5B13D40F2F7A7A0D5D2454054B875537E463840F7B050E9AE0F2840F146179860323840429ADF6DFCCD43409BD0D097DD525F404AB4D510C8A65440B75BF3A40D730B40B4589FEE913F1E409983F9EE57D24A4018DC399F8F7F49403889CF3A6716314013AC21F69F37F93FF29ED1403AB713405ED1F942F30132408F569EBF500735401E671301BEFD2040C803C8A10B6C0B4051F01DDF13E124402F38858EEF2528403390788AAE1D304072650CCF2DAD21404624409D21BFF73F044E4664EC4F1C406FC13A12341E3240CCBBC8D74FD93240E1D9F9340AE119403FA3F311615708405221E04E080D2740058E81F4D601504077AB43A72EDC5040E06BEC71EA033640AC38C5F2BD1A0C400611AE58156424405071D02DAD854A40CEFBC87D58044B40CEDE734ED36D3140B7793D5F0AD509403A45706989572A40CC9C3058DCF746401B65D345426A4640E8EEE08A50E82D40BFD0DA5A2E1A08408EB701EC67E52F406C280DC8C9534D4011E03C52107F4C404BD56DEDD8143240BAE1FA5F4FDF1B402F6AEDBB9DAF36401E17E811E1864E403E411E79CCF65840B18B72BB01924440</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="261">6E00000082DD92B89FCE274004CA0B8CB5473540CAF7720B54755040E5F05F6232064F40BCC927A6B67D3740D6A90017533E1B40A3EA1D0BB76B30403FF4D6C0A5A94640CD5E50D99C644540FA7D9D1303203840B1391DBE61860E405D838C8E3EAE2840E0F2C7EFAD774B403A38A9E357B8464034D6AB18E883324061D62B88B8AD0C40A65C83F5835B2C40D11E7437F84C4C40844068C5B02A4840A0EAEE8FEDEF31404402D50B04650A40C2197BD9B2FE254063FB0F19D7E445404B6113729480474092344F6782D73140192F176E7E661840B193F436E2C127404717824320264040848BD572AB094D40B2BFD155B71C3E40737BB67377D52340B11F2C23434B3040B997E1673A1A3B4082643A5DC08A4A406CFA3FE77B004240C62D01C121370C400414DA4B03E321404E4C9C933CD53E40F043E6F2843340406F32A5145C3A2F400BABA8D3D6D90040F384B85DD96A1140D676FC86F73C37401378EE4F06923840720E90A76DE32340ECBB3FEF806C1540F2315042FD7E1F40F69627C4050A38402B123F0296023A4060BE434582D42340801C2F119C0906405DD9AF882F46184077561FD62C51304056096F7BBDF6364071DF15BEE967224007907A49F919094055F20292737F2040AA3B5802585D43402CFB6BC95BD64740E0DC58BE070B3540B600642B1396214071F5CBAAC6B0274082BEB984A8084B405EB73ACA2A4259408A82FB878B944B407511233CBA4B0E4068CC0FF4E39D2540F80C522F01AC4940E9382A64CF594740755112AE936C304034BAEADEF7460140F7B68318F430154032C412E7FCA93140769DF671C00035404B7FC266219720406C6622F25317154022993D675D3F21401BEC8FB398CC2A40209C37EED15132408DB01660EEF91D409CDA18933B9D0940B504BFC27DAE1E4058D39FEA652E3940F26273B5ACD13640E66EF0FD627A1B40C7F9BE61D1F90B40027D8AED07DE29407AAE79513AF854402B4DFC061D2550408E1040D517433240F273C7B82A640840C45ECEFF206B28407ABA0CF4B34B4840E85FC1A1F52B4A40630DF2C8C09E3040F68749AB98830B40D798E5D2CCB2274087F7680291934740A6D1B81BEBF94540B766A3E591AA2D40FDC630F87DC00B400AFFBCF31ADA2F4072A8CF796984534002DB081E7F654E40A72F465C31CC33402E42C49303042140B76FFA0598793A4030152D5189055340835F991F5D175B40C7CFE193F88D4540</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="263">6E0000003151571CF8BE24404D883DF4EDFB3E408E041FC9D4B153406E266E46E043494090DD0FA7306337406A20142BD46A1E4052519096990C26403AAE141332AA4B407D2E80C18EE44740980D242BF4F339408399074AC61C11404AE80C4865E52A401AB6ED2634C25040B4E371013FDA4440F2BE4889CCB93040BDD670A15EAC1140CE34D0080A0434402007A2CA8D565340F2144D6A8B7648406179BCBD90CA324072EE36F85BAD0B408039CEE7A08F2D405BB69BD56B3849406E2D4C5DBE51434014AA954C7C413540D5DA0075A3CD1340D23A12DE04C928408BFFD364666935400BC787C3722244405272E0E0B6E24240FC42300397CC244017E5B9E298DD2F40ED44989278E14340B359D341EE2D4E40453424EE9640444009692F4B55C9104089684CAA16501E4042683593EF7C3C4091FB516E53B53F40E3DBFAE6080D32402B5751A8C262F83F513DF830AC9B1140379B711BD3693640DFC902A60B4935406AA8BEF3448A25405F77A5F5A6E80340643557117446194090C4C2251AF14340DF528CEB88E43B400CE4AE0CC7602640B98739EC51E8FB3F1A11DC617FC60B40C8FCD623DD2D3240FDBE2B7D11CC3140BC95FA0903CA2440305CBC2E0AFB0B4067445B80C90B1B409FBB99CB6BA04240BB9938521CC44440CB86CF03DCEE34407742E7D7A7AA224099D684EA2A153040C17B89761FB74E404D8EEE4DC0585840BEC9023542A14D407AD40D48DE3613404980D62791DB234043755F63CA4E4F4028EB3AD6B4EF4640F96E01AA81B3314047D7BEDC8BBAFA3FE56932C8FAB418402AB552B5DF94304074DAAA9091B733405CBB6CB29B0925406FA9473BBA6506401E91CA0F6EF9164088873C59A6B32640B937BD7B334230400E5A0D3C7C9023404C5A039AC8A2FA3FEE8BF252845A1040E7A136FAC0333440DE7749B390A6304059BD90E42E411C40A16E97F5EB6B0E4018B2D1209CC825404877BA167A835640E23BE5ECA8924F40645355BE230E33407F8D5270CCA11140698AE73E30852740E5FDF485023A50408631DEDFCE2345407FE2EFF153ED2E40E9F352EA48490D409F28A7E98927254041CD7149E7EB4440AA6784C72F9F3E4008DA271BD6033040F28E17572C0F0E402F99B537FFA02B40F84EFB1F25025140E6B4A0DDBE6F4840321E1F2B85F13440C4E635C845461F40DCCD0ECC60BB3E40484ED5BB680157406C1D565A4B91544093D4B17999C74440</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="267">6E0000009B0B41CAAFC01E404273AECA3E5D3540499701693AFF5440E1C9458CED034940548EA920D04C4140002B4C7C81E21240F3087F6E9435244028E6148F36CE40406EA79347A6C74140CA9A846EF6F0334088D252EE449012402F5EEA7BDEAF28401F605FC1790F47400C81F20DD8114040C951F00E0C9432405A097964C1FB164064CF6AA46E353340FF899CF0F6715040E0B70F82EBE64340E39535214CA339403B5F9F23DD051240D677F5DAC68B2B40EE7FAC74FC294F403154A532F9B244405E4A6F90A9723C400C2E94F66AF01840193ACBDC38FD28400C743971B85C4D40E768D379F8864C407FF7AF2074DD4640AD1EFE579B081B402D5CC750357E2F403CE30A70A2C24540BD0A9DD75BD848403C232C3CE2D43E406029FAB262B802403B6CDB2CD7881340AB5DB86A1B823340555337B1F3E43C402B568144C5EE2940D34158B9A1C3F23F54C5F165ABD10D408EEC5EE915A724400C367E829C5731401BF6F4D232DC2340820D606CF3480240B1FEAFC565B817403FC528A15E663640F5EF19AF14FE3140B356DFF9123226407E57244920D1F83F4462FA65A3F311405EE7925965BE324079E5C52C235932406A1BBA4BCE1A2640C1B93A819DF70B401D3C950C00311D4019342C3D819D384085776EE670BA414026FDA84504BB3540E037A27E64EE204004DDC996DE26294083E9D65EA3A9414089E9D9F58B224840CA65E0328B893E405A92FFCF7F270740C9FBA1CCF6CE284050B98CC1ECF451407B8B203794E144406EA06C9DB7A82C402AC3897F43ECF53F2EA03C8CE96D1A40DC961F72F36A3D40DCFB3BE6077A344063B47FF31A4F25403B6832BA2E320340C193EDCE3DCC1740EF275BB63335314047ACB8286ABF2E40A3613B009B9324400C4820432045F73FE7046469074515406C8CAAEF39E035406473B8FC6ECE30407A9EF11D75391B409EF5EDC5FB3A06407007D3560CA02940A263FC92BE1F5040749A93D6B08C4540E578BE2D9D7F2A40F69D320A9E9B1140E12A3BF17D953040891F157BEA055440A30109172DE649402F15A0F203A23640C18A7B667DD61040341621DC419627402486974D0E3250401EE8EF86C0344640A47CAE8D17A936405A655EF4A2610F4088B9C65616A028402EF3DE2F087A5140390C133AEF994840F24881B42B8E3A40E6C9BC5CB6BC2040DAE72AD432A535403B145A9E01D05440C3F0BE6F976759409FBB37F3659F5040</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id="274">6E0000001DCEFE3767C426403FCA6884500F3B4022159AC25619504002AC47225F084C40921AE737A4A03A40F2A01BC2F5601E40A0261163EDE7264078C7FB839C1049407E104B0EDAFF4C40EC00F41841613640527461B682A419406A2D9FD545B228404CAAB12DD3724C406ACB3DED6F9247408D5976DB38CC2F40791C81A0E8771340DA1E3FF353AB2F40258ED42D13AD4E40981409C82BD648404C661A91D3413340A388DC6AAB361140C491DADFBBAF254019CA1E2C63D34540889CE624ED8E4540CBC8A7148356364019582570BA9C18409ADEB4C4B39A2740AB3CE79AAE783F4041D92E16883B4840E2E9580A8AD73E40254686ABC8CC1440746C9706610725403C19CF6C4A6642409FD897E206E04E40B71A888D9A9F4340240DD4A6D90F03401CD8108610A2164017E4A73AE3694040AFB166668C4F45409319334F9BBA3340AFF6D594ADA504407DA790431FF2104009423D9CD13733409F19FA5CE1B03740AC9E011954972240F67BC37F549B0D40A2F68D3AB31823409680F79D5D9B39405C393F8CC99B374099180A9DE8052340C1E860DB6B16FD3F0AF7255EC2390F405CFDE2513A813140E8B05D6E8BE03640AF264061D4692840B5BADE4E36B603400E0C2743182A1840F5EFC883CBD04140293E841040C54540741CB16886B33240503DD0C66B2118408DA2BC19E16C2D40DAD3118A4FA04140CA5AD060C3445240C9C43C6982314240A12FD5F1685102409D4EEAD5CBFD1E4065F6655F31245140A2E1714406DA4B40E7E6EC6EE3CE33403773E3468CFC02401CFCC33469541540139BD3DDF51135409A09D215AFA435407CC48A06E02022407F944B2785281240A38AE0D7C5C62240989B9EF0F6A625403935122BBB2F2C4062729C8DBDCE1D406FB76088E8850240F81A7200BA971140D9BFBEDCE85A334090A9ECDCE5823340114F3B380B031C40358735BAF4AC0E40E16F0D4B185D2040974C17983DB25040940AB27D9B094E40DC70B33A35FC32405C5C4767D6E312409C7CC328590E2A40E0F75199D3595240D4D7F94AFC125040F89664B1DE3C3540148157D5115E16408ED9FD9DF6AE2940D8131D29DF454C402F6E1A7B33594840F181EA03FA1D31406094F643C1E41B40E1775287B2232B40CF776AD93F125240BC52178462044F40AFE45ADAEEDB334085EA33B985AF2C40505EB21706993B40B36DF1F1A5935F4058D4FFC582AA6140A514E8801DDE4940</Trial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><Trial ClassLabel="Tongue - cue onset (BCI experiment)" Id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rial><ClassList><Class Id="0">Foot - cue onset (BCI experiment)</Class><Class Id="1">Left - cue onset (BCI experiment)</Class><Class Id="2">Right - cue onset (BCI experiment)</Class><Class Id="3">Tongue - cue onset (BCI experiment)</Class></ClassList><Header FeatureVectorLength="110" NumberOfClasses="4" NumberOfTrials="288">Spectral Power of EEG Rhythms (WaveletTransform)</Header></TrainingData>